The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesis

Charles Massie, Andy G. Lynch, Antonio Ramos‐Montoya, +23

The EMBO Journal

UrologySystems BiologyHormonal ReceptorAndrogen Receptor FuelsCentral Metabolism +5

The Androgen Receptor Induces a Distinct Transcriptional Program in Castration-Resistant Prostate Cancer in Man

Naomi L. Sharma, Antonio Ramos‐Montoya, Vincent Zecchini, +7

Cancer Cell

Androgen ReceptorTranscriptional RegulationUrologyHormonal ReceptorDistinct Transcriptional Program +6

HES6 drives a critical <scp>AR</scp> transcriptional programme to induce castration‐resistant prostate cancer through activation of an <scp>E</scp> 2 <scp>F</scp> 1‐mediated cell cycle network

Antonio Ramos‐Montoya, Alastair Lamb, Roslin Russell, +17

EMBO Molecular Medicine

The ETS family member GABPα modulates androgen receptor signalling and mediates an aggressive phenotype in prostate cancer

Naomi L. Sharma, Falk Butter, Matthias Mann, +9

Nucleic Acids Research

Androgen ReceptorAndrogen Receptor SignallingTumor BiologyTranscriptional RegulationSignaling Pathway +17

First 500 cases of robotic‐assisted laparoscopic radical prostatectomy from a single UK centre: learning curves of two surgeons

Naomi L. Sharma, Dominic Lee, John McLoughlin, +6

British Journal of Urology

Deoxycytidine Kinase Expression Underpins Response to Gemcitabine in Bladder Cancer

Martin Kerr, Helen E. Scott, Blaž Grošelj, +4

Clinical Cancer Research

Detailed analysis of operating time learning curves in robotic prostatectomy by a novice surgeon

Harveer Dev, Naomi L. Sharma, Sarah Dawson, +2

British Journal of Urology

Evolution and oncological outcomes of a contemporary radical prostatectomy practice in a <scp>UK</scp> regional tertiary referral centre

Vincent J. Gnanapragasam, David Thurtle, Anandagopal Srinivasan, +12

British Journal of Urology

Whole blood mRNA in prostate cancer reveals a four-gene androgen regulated panel

Benjamin Thomas, Jonathan D. Kay, Suraj Menon, +19

Endocrine Related Cancer

General application of the National Institute for Health and Clinical Excellence (NICE) guidance for active surveillance for men with prostate cancer is not appropriate in unscreened populations

Lih‐Ming Wong, Richard B. Johnston, Naomi L. Sharma, +3

British Journal of Urology